Advanced searches left 3/3
Search only database of 12 mil and more summaries

Multiple Sclerosis International Federation

Summarized by PlexPage
Last Updated: 18 January 2022

* If you want to update the article please login/register

General | Latest Info

Multiple Sclerosis International Federation

FacebookMSInternationalFederation

There are now 2. 8 million people worldwide who have multiple sclerosis, according to most extensive global study to date. MS International Federation's most accurate estimate yet shows that there are at least 1 in 3 000 people living with disease. However, in countries with highest prevalence, this rises to as many as 1 in every 300 people. Atlas Of MS Reveals That Number Of People Living With MS Has Increased In Every World Region Since 2013. Although better counting methods, more accurate diagnosis rates and population growth are just some of factors behind rise, increased risk of developing MS cannot be ruled out. Neurological condition, which touch at least twice as many women as men, affects brain and spinal cord. Symptoms vary widely from person to person, but can include blurred tingling sensations, dizziness and fatigue. 85 percentage of people are initially diagnosed relapsing remitting MS where they experience periods of relapse and remission, whereas 12 percentage are initially diagnosed with progressive MS. Remaining 3 Percentage Are Given Unknown Disease Course At Initial Diagnosis. For everyone with condition, MS life unpredictable. Currently, every five minutes, someone, somewhere in world is diagnosed with MS. Typically, MS is diagnosed in people's 20s and 30s, but it can occur at any age, with global average age of diagnosis being 32 years. As this is age when people might be finding long-term partner, having children, and forging careers, it is important that support mechanisms are available to enable people to live lives they want. Despite common misconceptions though, MS is not condition of adults. Global Study Reveals That There Are At Least 30 000 Under-18s Living With MS. MS International Federation Calls For Stronger Awareness That Children And Young People Can Also Develop MS And Better Data Collection On Pediatric Cases Of MS. Although this is most extensive worldwide study that maps and counts MS, there are still big gaps in global evidence. MS International Federation calls on governments, health professionals, patient organisations and others to improve collection of data on MS. Only by doing this will true global burden of MS be visible.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

MS International Federation (MSIF)

MSIF brings together work of MS organisations to help people affected by MS around world. They: work to strengthen those organisations countries where there is little support for people with MS; campaign for increased awareness of disease, provide information to our members; and support international research into better treatments and ways to manage disease. In 2017 50 anniversary of MSIF movement, MSIF launched new five year strategy. Within this new strategy, they are working towards five strategic aims: better scientific understanding leading to new ways to treat, prevent and stop MS, Improved Access to effective treatments and health care Access to accurate and trustworthy information resources to make informed decisions to live well with MS Positive changes in policies and practices. Attitudes and behaviours that are obstacles to living well with MS stronger, broader MSIF movement made up of effective MS organisations, engage and strategic international collaborations

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

What are its main findings?

P. Browne, D. Chandraratna, and C. Angood report no disclosures relevant to manuscript. H. Tremlett is funded by Multiple Sclerosis Society of Canada and Michael Smith Foundation for Health Research and is Canada Research Chair for Neuroepidemiology and Multiple Sclerosis. She has received research support from US National Multiple Sclerosis Society, CIHR, and UK MS Trust. She has received speaker honoraria and / or travel expenses to attend conferences from Consortium of MS US National MS Society, University of British Columbia Multiple Sclerosis Research Program, Bayer Pharmaceutical, Teva Pharmaceuticals, ECTRIMS, UK MS Trust, Chesapeake Health Education Program, US Veterans Affairs, Novartis, and Consortium of MS Centers. Unless otherwise state, all speaker honoraria were either donated to MS charity or to unrestricted grant for use by her Research group. C. Baker reports no disclosures relevant to manuscript. B. Taylor receives research support from MS Research Australia and Australian National Health and Medical Research Council and is supported by Royal Hobart Hospital Research Foundation Senior Clinical Research Fellowship. He has served on Advisory Board for Biogen Idec and has received support to attend conferences from Bayer Pharmaceutical and Novartis. Thompson is of MSIF International Medical and Scientific Board, Chair of Eisai-UCL Joint Steering Committee for Neuroscience, member of Imanova Advisory Board, and trustee of Development Foundation Brain Appeal, National Hospital for Neurology and Neurosurgery, Queen Square. He received grants from NIHR as Senior Investigator; is co-recipient of grants from Wolfson Foundation, MRC, Wellcome Trust, MS Society of GB, SRH Holding, and Eisai Inc; received honorarium support for travel for consultancy from Genzyme; received honoraria and support for travel for invited lectures from Novartis, Serono Symposia International Foundation, Teva, and Remedica; and receive honorarium as Editor-in-Chief for Multiple Sclerosis Journal, free subscription as member of Lancet Neurology Editorial Board, and publishing royalties from Cambridge University Press. Go to Neurology. Org for full disclosures.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2022 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.